These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 29091261)
21. Citrobacter rodentium mouse model of bacterial infection. Crepin VF; Collins JW; Habibzay M; Frankel G Nat Protoc; 2016 Oct; 11(10):1851-76. PubMed ID: 27606775 [TBL] [Abstract][Full Text] [Related]
22. Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Neumann M; Steimle A; Grant ET; Wolter M; Parrish A; Willieme S; Brenner D; Martens EC; Desai MS Gut Microbes; 2021; 13(1):1966263. PubMed ID: 34530674 [TBL] [Abstract][Full Text] [Related]
23. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen. Reid-Yu SA; Small CL; Coombes BK Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576 [TBL] [Abstract][Full Text] [Related]
24. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. Bergstrom KS; Kissoon-Singh V; Gibson DL; Ma C; Montero M; Sham HP; Ryz N; Huang T; Velcich A; Finlay BB; Chadee K; Vallance BA PLoS Pathog; 2010 May; 6(5):e1000902. PubMed ID: 20485566 [TBL] [Abstract][Full Text] [Related]
25. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Meiners J; Palmieri V; Klopfleisch R; Ebel JF; Japtok L; Schumacher F; Yusuf AM; Becker KA; Zöller J; Hose M; Kleuser B; Hermann DM; Kolesnick RN; Buer J; Hansen W; Westendorf AM Front Immunol; 2019; 10():1386. PubMed ID: 31275322 [TBL] [Abstract][Full Text] [Related]
26. Investigation of Host and Pathogen Contributions to Infectious Colitis Using the Citrobacter rodentium Mouse Model of Infection. Bosman ES; Chan JM; Bhullar K; Vallance BA Methods Mol Biol; 2016; 1422():225-41. PubMed ID: 27246037 [TBL] [Abstract][Full Text] [Related]
27. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection. Maiti AK; Sharba S; Navabi N; Lindén SK PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907 [TBL] [Abstract][Full Text] [Related]
28. Autophagy in the intestinal epithelium regulates Citrobacter rodentium infection. Inoue J; Nishiumi S; Fujishima Y; Masuda A; Shiomi H; Yamamoto K; Nishida M; Azuma T; Yoshida M Arch Biochem Biophys; 2012 May; 521(1-2):95-101. PubMed ID: 22475450 [TBL] [Abstract][Full Text] [Related]
29. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. Spehlmann ME; Dann SM; Hruz P; Hanson E; McCole DF; Eckmann L J Immunol; 2009 Sep; 183(5):3332-43. PubMed ID: 19675161 [TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Khan MA; Ma C; Knodler LA; Valdez Y; Rosenberger CM; Deng W; Finlay BB; Vallance BA Infect Immun; 2006 May; 74(5):2522-36. PubMed ID: 16622187 [TBL] [Abstract][Full Text] [Related]
32. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. Bry L; Brenner MB J Immunol; 2004 Jan; 172(1):433-41. PubMed ID: 14688352 [TBL] [Abstract][Full Text] [Related]
33. Selective enrichment of commensal gut bacteria protects against Citrobacter rodentium-induced colitis. Vong L; Pinnell LJ; Määttänen P; Yeung CW; Lurz E; Sherman PM Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(3):G181-92. PubMed ID: 26067845 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells. Sharba S; Navabi N; Padra M; Persson JA; Quintana-Hayashi MP; Gustafsson JK; Szeponik L; Venkatakrishnan V; Sjöling Å; Nilsson S; Quiding-Järbrink M; Johansson MEV; Linden SK Virulence; 2019 Dec; 10(1):97-117. PubMed ID: 30665337 [TBL] [Abstract][Full Text] [Related]
35. Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence. Lamas B; Michel ML; Waldschmitt N; Pham HP; Zacharioudaki V; Dupraz L; Delacre M; Natividad JM; Costa GD; Planchais J; Sovran B; Bridonneau C; Six A; Langella P; Richard ML; Chamaillard M; Sokol H Gut; 2018 Oct; 67(10):1836-1844. PubMed ID: 28790160 [TBL] [Abstract][Full Text] [Related]
36. Epithelial talin-1 protects mice from Latour YL; Allaman MM; Barry DP; Smith TM; Williams KJ; McNamara KM; Jacobse J; Goettel JA; Delgado AG; Piazuelo MB; Zhao S; Gobert AP; Wilson KT Gut Microbes; 2023; 15(1):2192623. PubMed ID: 36951501 [TBL] [Abstract][Full Text] [Related]
37. Role of bacterial intimin in colonic hyperplasia and inflammation. Higgins LM; Frankel G; Connerton I; Gonçalves NS; Dougan G; MacDonald TT Science; 1999 Jul; 285(5427):588-91. PubMed ID: 10417389 [TBL] [Abstract][Full Text] [Related]
38. Divergent Innate and Epithelial Functions of the RNA-Binding Protein HuR in Intestinal Inflammation. Christodoulou-Vafeiadou E; Ioakeimidis F; Andreadou M; Giagkas G; Stamatakis G; Reczko M; Samiotaki M; Papanastasiou AD; Karakasiliotis I; Kontoyiannis DL Front Immunol; 2018; 9():2732. PubMed ID: 30532756 [TBL] [Abstract][Full Text] [Related]
39. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Shiomi H; Masuda A; Nishiumi S; Nishida M; Takagawa T; Shiomi Y; Kutsumi H; Blumberg RS; Azuma T; Yoshida M Infect Immun; 2010 Jun; 78(6):2653-66. PubMed ID: 20351140 [TBL] [Abstract][Full Text] [Related]
40. A mouse model of Wang W; Li Y; Guo X STAR Protoc; 2020 Dec; 1(3):100218. PubMed ID: 33377111 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]